Position in CELC
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$603,458
+$76,133 QoQ
Shares Held
5,287
0.0% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AlTi Global, Inc. holds $5,270,139 across 9 Biotechnology names. CELC ranks #4 (11.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,857 | $1,434,792 | |
| 2 | RPRX |
Royalty Pharma plc
|
25,073 | $1,202,751 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
1,492 | $781,017 | |
| 4 | CELC |
Celcuity Inc.
This page
|
5,287 | $603,458 | |
| 5 | MDXG |
Mimedx Group, Inc.
|
95,212 | $376,087 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
673 | $300,520 | |
| 7 | RLMD |
Relmada Therapeutics, Inc.
|
31,975 | $222,546 | |
| 8 | MRNA |
Moderna, Inc.
|
4,220 | $214,375 |
All Filings in CELC
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $603,458 | 5,287 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $527,325 | 5,287 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $261,177 | 5,287 | Shares | Defined | 2025-11-06 | |
| No filing history on record for this holder in this stock. | ||||||